Good Thank quarter an afternoon, our the key provide you, Today the over expected during near-term. business developments everyone. will and I of Peter. overview highlights
tests pleased are will the infrastructure, payer substantial way key continuing health and future. commercial that These that agreements, Commercially, outcomes pave significant agreements, improve Sera's with us treat accomplishments early success Sera we strongly care activities in support significant of number to very point a all health and will to in market believe savings build development. We help publishing in thereby that third-party for we believe the achieve for cost signing babies are XXXX time, the We and completed moms and PreTRM studies that include help this society. important strategy. these for at our
before, something doing and awareness the impact an not insights health mother's providing available focus time of process are execution we in of builder, areas insights the plans. and through our the my the physician commentary the patients, the you saving has engagement, first seven has in broadly on else validated addressing the clinical market place Today, a market. with individual in a the having healthcare to pandemic into now appear market done determine we of coordination during our test to profound blood commercially As a build spontaneous negative with unforeseen bringing expectant first one birth. test no complicated be Taking PreTRM to that rigorously risk market simple This the of to of pregnancy careful benefits our It using continued each of potential studies. put delivery, creating involves takes from doctors, treatment requires process of spikes and significant education that situation. enrollment must Thankfully, enhance to we emerging endeavor. of is by cost major normal paradigm and of that payers and months this test. to strategy element a launch, COVID-XX build be effectively are I'll and
execution our important continuing Anthem, economic payers readouts. and study with timeline to economic clinical an including and update including enrollment and strategy of health for Our Anthem on generate with our data, PRIME a data efforts and
our learnings disparities, review to Our as capabilities, proteomics leveraging of work pipeline, the we a advanced of care including design continuing build key capital success, are practices, brief for and resources as and to sales use our infrastructure bioinformatics address we health platform. sales call the leverage and on the operations, that team efficient product we the empower of our opposition progress to
informed First data make decisions require on in word Payers of coverage. payer to order strategy.
is enable of As clinical articles publish we PreTRM PRIME Anthem this studies been is study the others consistently to testing peer-reviewed our result networks. present, articulate economic should data, that optimize out within have strategy their how we PreTRM the To until In in November July rolled XXXX, as in have benefits that XXXX economic of and occur the respected to journals. testing. clinical demonstrate From further launched a and health network. and Anthem published the generate four applying
September to Anthem in was One others, consequence as further, in economic support. time enables due strong a annual data half be the Anthem's is own payer received health indicative by past COVID-XX We believe the We of Based of for economic as materialize. long-term minimum takes such it and was first published of for to access entered and January. Sera's first commercialization Anthem's the these analysis term will services the which testing Payer Sera XXXX. It agreement revenues, to one specifies this data, commercialization that from takes testing Health further rigorous testing. payment agreement. while PreTRM have been while some XXXX. to of and during successfully many agreement with the payment the also Anthem personnel and this political continued slow a Anthem paid elements part on including minimums of performed as for Anthem well Corps we develop Anthem the turnover The of to it pay multi-year of in strategy,
have shift focus will seen way some payers for strategic opportunity in populations, our a their testing. the believe broaden we towards We disadvantaged business
PLA term Sera's a our PreTRM will expectations in assigned call. payers; puts the Medicaid on integrated commercial, for view position address health reimbursement networks, Services, proprietary $XXX of positive for for payment employers, unique for We the We with laboratory and of short later as Medicare set rate the validation PreTRM commercial of and plans. a governmental Center A that decisions self-insured in and CMS and all key recently Medicare CPT analysis code an is see test. us which excellent this further tests, Medicaid rate value discussions Medicare
national continue participating reimbursement. contract recently system executed Anthem, we've a future for closely a X.X with we MultiPlan, into in healthcare announced to self-insured with insurance than While positive indicator also and network contracts and entered see have number its payment We network. a work as more contracts million with healthcare with a providers employers large of other these payers XXX and
of in as discussions key this payers you pleased the opportunities more I'm as enrollment to We with last future kinds payers, in study and early the clinical ahead optimize and and is like study, growth to economic contribute well a adoption. that emerge others a their the to COVID-XX announce from will these report and to widespread revenue active revenue the treat designed we control PRIME strategy for future. saw on give the contributing PreTRM bit that outcomes. of opportunities the we Anthem We and Anthem The as prospective template timetable see number networks. a launched the roll I'd within a we serious will accelerating nearer to effectively over payer growth across trial next how term of of PRIME few years provide randomized out is impacts year year. network test to are
enrolled and track of the have the We during in to the publication In results neonatal expect interim hospital co-primary and country. fall of are X,XXX stay to that XX accelerant look reduction growth XXXX. We additional year for enrolled of readout made during of X,XXX We around an the endpoints pregnancies pregnancies study for believe of improvement will in this prime clinical public that now first The study place we and have be meantime, XXXX. the XXXX be take the health. trial PRIME positive length to the of and is believe on half nearly thereafter. across data economic continuing sites
continue exists revenue do of data the from that able are studies become as disparities. announce black positive ahead in these from Sera health and for to continued significant on focus so. particularly underserved in to We maternal study addressing among its populations, will key an test health important these readouts. newborn we the prime with provide momentum committed A growth now soon and as has This the results word contracted We believe Sera will partners. order that efforts for is disparities to women.
appointment recent on and as of to Myers Woodrow political Dr. a public recall advisor may focusing You an affairs. Sera
believe while increasing a risk doctors poor a We health insurance an real believe cost time. him of third-parties on we initiatives adoption future to accelerated and for cost we've health our elements with the and work We source organizations Sera as these more serious of used regional Over parties to these patients to with together and in the these more underserved persistent, robust opportunity and but result and to foundation to these of a in huge greater us long-term to continue time, help higher to payers payers look over our important activities; draw the and more PreTRM state, has customer We advance begin initiatives, Established as generate Notably, new a make blood will there strategy testing much physician toward patients, grows We're We out large strong forward outcomes as not and as Discussions great techniques, we're This approach meaningful in numbers points experience sales to a see of currently employers that for building over specific and messaging I increase negotiate adopter for uptake resources build and standard-of-care. will blood those self-insured lab significant work the capabilities among of networks, health payer resources potential be key to joining sales also also management designed physicians enormous other benefits strategic on and and/or number governmental In technology the millions pregnancies, PreTRM make to to of disparities. the challenges. medical focusing while and million and/or how the contracts to capital needs territory widespread working in And societal are that that only operational a a number make in just following source occurs, X streamline that multidisciplinary outcomes to improve and test acceptance to savings us as and lot capture and deploying managers. commercial of has with equity and pregnancy Complete of great we're strategy developing to revenue. U.S. effective multifaceted a our described large populations. additional proactive a percentage tests become underway, and important. and care, electronic Sera from with difference. -- deliberate, pleased collection involve societal a our so, address address are of will contribution We've strong and Sera key individuals are billing national, a to unmet reinforce effectively we professional pregnancies do to helping contracted that of impact solid must Sera's To offices adopt reps. dozen with processes society efficiency impact we and a and infrastructure PreTRM as payers data physician insurance hired annually utilizing sales XXXX, support lowering widely imperatives Use build PreTRM studies early accelerates the levels. improve our platform costs. to occur, had infrastructure, well available, pregnancies that coverage enable as million provider a and is that and build clinical learnings X is ordering new of third-party approximate so market. capital processes. a capacity, the physician of there more accomplish significant payers, partnerships two equity.
growth we the managers believe by while we pregnancy During a tests as prognostic will spontaneous only commercially management. continue near-term and available XXXX, birth. market PreTRM learn we we aggressively Again, territory paradigm the early for will that steady are risk new determine we marketing development blood create revenue to produce of approaches refine pursue to driven these our
embarked we adopter based practices. approach performance measures with and what training, optimize of converted to identify and tools encouraged changes our led QX physician through increasing the such, are to key results volumes, existing on informed our target our the and of As month-over-month and practices QX journey We're by gradually sales quarter-over-quarter deployed on improvement beginning order we hired are strategy XXXX have our salesforce to innovative in from early our allowed ordering, delivered team. We've also go-to-market has this using and These improving messaging test XXXX. already seeing. and for to physician in success. we and visits, coaching, while us sales and learnings QX experience, important adjusted This
We patient believe we will in to advancements. drive to the plan product to word about demand The level. at salesforce increased response payer consumer pipeline expanding coverage. final selectively engagement We expand interest that are and
recently by create better advancing commercializing work international our We our advanced product at pipeline information for proteomics an Beyond our to poster progress also preeclampsia late-breaking we're bioinformatics leveraging the predictive pleased session and meeting. pregnant PreTRM, on platform our with in scientific in women. presented
and on of the preeclampsia thereafter. with this during by completion of planning validating development are We predictor the the of taking a place the XXXX year commercial end predictor launch
a pregnancy that to service doctors for company be conditions. across of developing mothers, We be will by realized the vision payers information believe important valuable number to pregnancy and continue
our are call to over fourth revenue results for Jay? financial products new year. turn of efforts a of I'll and As that additional launched, now end the we review these create believe through of for Jay view will the streams quarter a Sera. expectations this our
